Aquestive Therapeutics logo
Aquestive Therapeutics AQST
$ 3.62 -0.69%

Quarterly report 2024-Q3
added 11-04-2024

report update icon

Aquestive Therapeutics Operating Cash Flow 2011-2024 | AQST

Annual Operating Cash Flow Aquestive Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-6.38 M -9.82 M -33 M -45.5 M -60.2 M -13 M 5.82 M - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
5.82 M -60.2 M -23.1 M

Quarterly Operating Cash Flow Aquestive Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - -10.4 M - - - 8.82 M - -18.2 M - -14.5 M - -24.9 M - -14.1 M - -31.9 M -23.6 M -13.6 M - -49.6 M -34.8 M -17.7 M - -10.2 M 1.3 M 785 K - 13.2 M -2.39 M - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
13.2 M -49.6 M -14.2 M